The conjugated products were tested on different cancer cell lines (MCF-7, BT-474, and MCF-10A) and displayed enhanced cytotoxicity in HER2-positive cells (MCF-7 and BT-474), with the cysteine conjugate significantly more cytotoxic than the starting complex. The gene discussed is ERBB2; the disease is cancer.